Found: 20
Select item for more details and to access through your institution.
Impact of prior systemic therapy on lymphocytic infiltration in surgically resected breast cancer brain metastases.
- Published in:
- Breast Cancer Research & Treatment, 2023, v. 199, n. 1, p. 99, doi. 10.1007/s10549-023-06908-0
- By:
- Publication type:
- Article
History of infertility and risk of breast cancer: a prospective cohort study.
- Published in:
- Breast Cancer Research & Treatment, 2023, v. 199, n. 1, p. 185, doi. 10.1007/s10549-023-06907-1
- By:
- Publication type:
- Article
Does a brief surgeon training in negotiation theory principles decrease rates of contralateral prophylactic mastectomy?
- Published in:
- Breast Cancer Research & Treatment, 2023, v. 199, n. 1, p. 119, doi. 10.1007/s10549-023-06891-6
- By:
- Publication type:
- Article
mTOR pathway candidate genes and physical activity interaction on breast cancer risk in black women from the women's circle of health study.
- Published in:
- Breast Cancer Research & Treatment, 2023, v. 199, n. 1, p. 137, doi. 10.1007/s10549-023-06902-6
- By:
- Publication type:
- Article
A prediction model for distant metastasis after isolated locoregional recurrence of breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2023, v. 199, n. 1, p. 57, doi. 10.1007/s10549-023-06901-7
- By:
- Publication type:
- Article
De-ESCAlating RadioTherapy in breast cancer patients with pathologic complete response to neoadjuvant systemic therapy: DESCARTES study.
- Published in:
- Breast Cancer Research & Treatment, 2023, v. 199, n. 1, p. 81, doi. 10.1007/s10549-023-06899-y
- By:
- Publication type:
- Article
Treatment-related side effects among Hispanic and non-Hispanic white long-term breast cancer survivors by tamoxifen use and duration.
- Published in:
- Breast Cancer Research & Treatment, 2023, v. 199, n. 1, p. 155, doi. 10.1007/s10549-023-06900-8
- By:
- Publication type:
- Article
Impact of multifocal or multicentric disease on local recurrence and survival in breast cancer patients with or without BRCA1/2 variants.
- Published in:
- Breast Cancer Research & Treatment, 2023, v. 199, n. 1, p. 25, doi. 10.1007/s10549-023-06904-4
- By:
- Publication type:
- Article
Implications for surveillance for breast cancer patients based on the internally and externally validated BRENDA-metastatic recurrence score.
- Published in:
- Breast Cancer Research & Treatment, 2023, v. 199, n. 1, p. 173, doi. 10.1007/s10549-023-06898-z
- By:
- Publication type:
- Article
Using Oncotype DX breast recurrence score® assay to define the role of neoadjuvant endocrine therapy in early-stage hormone receptor-positive breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2023, v. 199, n. 1, p. 91, doi. 10.1007/s10549-023-06890-7
- By:
- Publication type:
- Article
Pegylated liposomal doxorubicin (Duomeisu<sup>®</sup>) monotherapy in patients with HER2-negative metastatic breast cancer heavily pretreated with anthracycline and taxanes: a single-arm, phase II study.
- Published in:
- Breast Cancer Research & Treatment, 2023, v. 199, n. 1, p. 67, doi. 10.1007/s10549-023-06894-3
- By:
- Publication type:
- Article
BRCA1 and BRCA2 germline mutation analysis from a cohort of 1267 patients at high risk for breast cancer in Brazil.
- Published in:
- Breast Cancer Research & Treatment, 2023, v. 199, n. 1, p. 127, doi. 10.1007/s10549-023-06892-5
- By:
- Publication type:
- Article
Antitumor activity of the PI3K δ-sparing inhibitor MEN1611 in PIK3CA mutated, trastuzumab-resistant HER2 + breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2023, v. 199, n. 1, p. 13, doi. 10.1007/s10549-023-06895-2
- By:
- Publication type:
- Article
Adaptive immune receptor features related to breast cancer tissue in Kenyan patients: high immunoglobulin gene expression and high levels of gamma-delta T-cells.
- Published in:
- Breast Cancer Research & Treatment, 2023, v. 199, n. 1, p. 207, doi. 10.1007/s10549-023-06897-0
- By:
- Publication type:
- Article
Reproducibility and intratumoral heterogeneity of the PAM50 breast cancer assay.
- Published in:
- Breast Cancer Research & Treatment, 2023, v. 199, n. 1, p. 147, doi. 10.1007/s10549-023-06888-1
- By:
- Publication type:
- Article
Aromatase inhibition plus/minus Src inhibitor saracatinib (AZD0530) in advanced breast cancer therapy (ARISTACAT): a randomised phase II study.
- Published in:
- Breast Cancer Research & Treatment, 2023, v. 199, n. 1, p. 35, doi. 10.1007/s10549-023-06873-8
- By:
- Publication type:
- Article
Neoadjuvant pegylated liposomal doxorubicin- and epirubicin-based combination therapy regimens for early breast cancer: a multicenter retrospective case–control study.
- Published in:
- Breast Cancer Research & Treatment, 2023, v. 199, n. 1, p. 47, doi. 10.1007/s10549-023-06867-6
- By:
- Publication type:
- Article
The effects of exercise and diet on oxidative stress and telomere length in breast cancer survivors.
- Published in:
- Breast Cancer Research & Treatment, 2023, v. 199, n. 1, p. 109, doi. 10.1007/s10549-023-06868-5
- By:
- Publication type:
- Article
Post-diagnostic statin use and breast cancer-specific mortality: a population-based cohort study.
- Published in:
- Breast Cancer Research & Treatment, 2023, v. 199, n. 1, p. 195, doi. 10.1007/s10549-022-06815-w
- By:
- Publication type:
- Article
Discordance between PAM50 intrinsic subtyping and immunohistochemistry in South African women with breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2023, v. 199, n. 1, p. 1, doi. 10.1007/s10549-023-06886-3
- By:
- Publication type:
- Article